# FDA Inspection 1108391 - Carter BloodCare - Arlington - October 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/ed4b4d1d-438e-432d-8cd3-0c5fac91c5b4
Source feed: FDA_Inspections

> FDA Inspection 1108391 for Carter BloodCare - Arlington on October 17, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108391
- Company Name: Carter BloodCare - Arlington
- Inspection Date: 2019-10-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1271731 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/affc848c-bfb6-4cdb-8bed-b2b996a042d5)
- [FDA Inspection 1271731 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/ede33cce-5493-4f12-9926-e832040a1a45)
- [FDA Inspection 1058076 - 2018-05-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/d92af8fd-cbd9-44a0-85bf-0d4d66f790c1)
- [FDA Inspection 989472 - 2016-09-15](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/e12bf00f-913b-43c7-8690-ad3545dc1e57)
- [FDA Inspection 875657 - 2014-04-23](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-arlington/3e88375e-33fe-4952-b4d6-3bd6c3c991c3)

Company: https://www.keypedia.com/companies/carter-bloodcare-arlington/5e6757cb-1da9-4f82-b400-e12e813f38a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d